CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (ADHD) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline landscape. Attention deficit hyperactivity ... Read More
-
Sedation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Sedation (Central Nervous System) pipeline landscape.Sedation is the depression of irritability or agitation. Symptoms include talk slowly and may slur their ... Read More
-
Diabetic Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type ... Read More
-
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genetic Disorders) pipeline landscape. Sandhoff disease is an inherited lipid storage ... Read More
-
Obsessive-Compulsive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Obsessive-Compulsive Disorder (Central Nervous System) pipeline landscape. Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that ... Read More
-
Alcohol Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Alcohol Addiction (Central Nervous System) pipeline landscape. Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms ... Read More
-
Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Dementia (Central Nervous System) pipeline landscape. Dementia is the loss of mental functions such as thinking, memory, and reasoning that is ... Read More
-
U.S. Contrast Media Market Size, Share & Trends Analysis Report By Type (Gadolinium, Iodinated), By Application (Cardiovascular, Neurological Disorders), By Modality (MRI, X-ray/CT Scan), And Segment Forecasts, 2022 - 2030
... & Trends The U.S. contrast media market is anticipated to reach USD3.36 billion by 2030, registering a CAGR of 4.12% over the forecast period, according to a new report by Grand View Research, Inc. The ... Read More
-
Central Nervous System Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... with a revenue of approximately USD 4,190.84 million in 2021, and it is expected to reach USD 7,113.47 million by 2027. COVID-19 cases across the world had a profound impact on the CNS biomarkers market. ... Read More
-
India Geriatric Care Services Market, by Services (In-Home Care, Hourly Adult Care, Hospice Care, Palliative Care, Assisted Living, and Nursing Home), by Service Provider (Public and Private), and by Disease Indication (Dementia, Parkinson’s Disease, Cancer, Stroke, Osteoarthritis, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Stroke, Osteoarthritis, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Geriatric care management integrates health care and psychological care with other necessary services such as housing, home care services, nutritional services, ... Read More
-
Global Oligonucleotide Synthesis Market Size study, By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, Equipment), By Application (Research Applications {PCR, Sequencing, Other Research Applications}, Diagnostic Applications), By Type (Antisense Oligonucleotide-Based Therapies, Rnai Oligonucleotide-Based Therapies, Cpg Oligonucleotide-Based Therapies, By Disease Type:, Neurological Disorders, Infectious Diseases, Other Diseases), By End-Use (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Cros And Cmos, Academic Research Institutes), and Regional Forecasts 2022-2028
... Therapies, By Disease Type:, Neurological Disorders, Infectious Diseases, Other Diseases), By End-Use (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Cros And Cmos, Academic Research Institutes), and Regional Forecasts 2022-2028Global Oligonucleotide Synthesis Market is valued approximately ... Read More
-
Remote Patient Monitoring (RPM) Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Homecare, Patients, Payers) - Global Forecast to 2027
... monitoring market is projected to reach USD 175.2 Billion by 2027 from USD 53.6 Billion in 2022, at a CAGR of 26.7% during the forecast period. The rising geriatric population and the growing need to ... Read More
-
Middle East and Asia Pacific Cell and Gene Therapy Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - ... Read More
-
Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines), End User - Global Forecast to 2027
... estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of ... Read More
-
Smart Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare)
... End User (Hospitals and Clinics, Research Institutes, and Home Healthcare) The global Smart Pills market size is projected to reach US$ 9,061.29 million by 2028 from US$ 4,019.30 million in 2021. The global Smart Pills ... Read More
-
Global Psychedelic Drugs Market: Analysis By Indication (ADHD, MDD, Bipolar, Migraine, Anxiety, Parkinson’s Disease, OUD, Alzheimer’s Disease, AUD, TUD, Eating Disorder, and Narcolepsy) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... Scope of the Report The report provides an in depth analysis of the global psychedelic drugs market by value, by indication, etc. The report also provides a detailed analysis of the COVID-19 impact on the ... Read More
-
Optogenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... a CAGR of 3.86% during 2022-2027. The ongoing COVID-19 pandemic globally is expected to have a significant impact on the optogenetics market. According to the article published by PUS University in February 2022, by Shanet ... Read More
-
Pharmaceutical Drugs Market Covering Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; O
... 2021: Covid 19 Impact and Recovery The global pharmaceutical drugs market grew from $771.16 billion in 2015 to $975 billion in 2020 at a CAGR of 4.80%. The global pharmaceutical drugs market is expected to ... Read More
-
2022 Global Forecast for Parkinson'S Disease Treatment (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) and End user (Hospitals, Ambulatory Surgical Centers, and Others: Global Opportunity Analysis and Industry Forecast, 2021–2030
... Ophthalmology, Neurology, and Others) and End user (Hospitals, Ambulatory Surgical Centers, and Others: Global Opportunity Analysis and Industry Forecast, 2021–2030 The regenerative medicine market was valued at $10,107.32 million in 2020, and is estimated to ... Read More
-
Telemedicine Market Analysis and Forecast to 2031: By Service (Tele-consulting, Tele-monitoring, Tele-education/training), By Type (Telehospital, Telehome), By Specialty (Cardiology, Gynecology, Neurology, Orthopedics, Dermatology, Mental Health), By Delivery Mode (Web/Mobile {Telephonic, Visualized}, Call Centers) and Region
... The global telemedicine market was valued at USD 60,908.9 million in 2021 and it is anticipated to grow up to USD 4,35,880.7 million by 2031, at a CAGR of 21.4% during the forecast period. Telemedicine, ... Read More
-
U.S. Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin’s, Blood Factors, Peptide Antibiotics, and Others), by Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online ... Read More
-
Surgical Sealants and Adhesives Market by Product Type (Natural Biological Sealants & Adhesives and Semi-Synthetic Sealants & Adhesives), Indication (Tissue Sealing & Hemostasis and Tissue Engineering), and Application (Central Nervous System, General Surgeries, Cardiovascular Surgeries, Cosmetic Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
... Cosmetic Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030 The surgical sealants & adhesives market was valued at $2699.2XXX million in 2020, and is estimated ... Read More
-
U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The U.S. clinical ... Read More
-
Global Lewy Body Dementia Treatment Market Size study, by Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, Modafinil) by Application Type (Parkinson’s Disease, Alzheimer’s Disease) by Mode of Purchase (Prescription and Over the Counter) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028 Global Lewy Body Dementia Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a ... Read More
Research Assistance
